ClinicalTrials.gg
CompletedNCT06629662SLEEVEROBOPUpdated Jul 10, 2026

Robotic Versus Laparoscopic Sleeve Gastrectomy

An interventional study of Sleeve gastrectomy in Robotic Surgery, sponsored by University of Naples. Completed at 1 site in Italy. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-07-10.

Sponsored by University of Naples · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Sleeve gastrectomy is the most commonly performed bariatric procedures. Robotic surgery seems to add more precision to the surgical interventions. However, robotic bariatric procedures appear to be burdened by longer operative time.

Aim of the investigators is to prospectively and randomly submit patients suffering from obesity to robotic or laparoscopic surgery in order to compare outcomes.

02

Conditions studied

  • Robotic Surgery

Keywords

  • Robotic surgery
  • Sleeve Gastrectomy
  • Bariatric surgery
03

In context

Lead sponsor

University of Naples is the lead sponsor of 11 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • According to IFSO (International Federation for the Surgery of Obesity)/ASMBS (American Society for Metabolic and Bariatric Surgery) 2023 guidelines

Exclusion criteria

Exclusion Criteria:

  • Previous bariatric or abdominal surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (actual)

Study arms

  • Active comparator
    Laparoscopic sleeve gastrectomy

    Patients undergoing traditional sleeve gastrectomy

    Procedure: Sleeve gastrectomy

  • Active comparator
    Robotic sleeve gastrectomy

    Sleeve gastrectomy with DaVinci robot

    Procedure: Sleeve gastrectomy

Interventions

  • ProcedureSleeve gastrectomy

    Sleeve gastrectomy with laparoscopic or robotic approach

06

What researchers measure

Primary outcomes

  1. Operative time

    Operative time in minutes (Docking plus console time for the robotic procedures)

    Time frame: From the Veress needle insertion at the beginning of the surgical intervention to the last skin stich

Secondary outcomes

  1. Intraoperative bleeding

    Bleeding during the surgical procedure

    Time frame: From the Veress needle insertion at the beginning of the surgical intervention to the last skin stich

  2. Postoperative bleeding

    Bleeding after the end of the procedure

    Time frame: From the end of the procedure to postoperative day 30

  3. Conversion to Laparoscopy

    Conversion to laparoscopy

    Time frame: From the Veress needle insertion at the beginning of the surgical intervention to the last skin stich

  4. Conversion to Laparotomy

    Conversion to laparotomy

    Time frame: From the Veress needle insertion at the beginning of the surgical intervention to the last skin stich

  5. Postoperative Leak

    Leak from the staple line

    Time frame: From the end of the procedure to postoperative day 30

  6. Postoperative Bowel Obstruction

    Bowel obstruction

    Time frame: From the end of the procedure to postoperative day 30

  7. Postoperative nausea

    Postoperative nausea measured with a Visuo Analogic Scale (VAS) from 0 (no nausea) to 10 (not tolerable nausea)

    Time frame: From the end of the procedure to postoperative hour 24

  8. Postoperative vomit

    Postoperative vomit measured with a Visuo Analogic Scale (VAS) from 0 (no nausea) to 10 (not tolerable vomit)

    Time frame: From the end of the procedure to postoperative hour 24

07

Study locations

1 site
  • University of Naples Federico II
    Naples, Italy 80131, Italy
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2024 to primary completion in Jul 2026, 21 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 3, 2024
First posted
Oct 8, 2024
StartActual
Oct 1, 2024
Primary completionActual
Jul 1, 2026
CompletionActual
Jul 1, 2026
Last update
Jul 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06629662
Lead sponsor
University of Naples
Responsible party
Antonio Vitiello (MD PhD Researcher, University of Naples) — Principal investigator
First posted
Oct 8, 2024
Start date
Oct 1, 2024
Primary completion
Jul 1, 2026
Completion
Jul 1, 2026
Last update
Jul 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion